Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

CCO Oncology Podcast - En podcast af Clinical Care Options

Prøv Podimo gratis! i 30 dage

Et univers fyldt med hundredvis af eksklusive podcasts & lydbøger, klik her for at prøve

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses using targeted therapies in patients with FLT3- or IDH1/2-mutated AML.